160 related articles for article (PubMed ID: 26924665)
1. Morphological heterogeneity in ductal adenocarcinoma of the pancreas - Does it matter?
Verbeke C
Pancreatology; 2016; 16(3):295-301. PubMed ID: 26924665
[TBL] [Abstract][Full Text] [Related]
2. Pathology reporting of pancreatic cancer following neoadjuvant therapy: challenges and uncertainties.
Verbeke C; Löhr M; Karlsson JS; Del Chiaro M
Cancer Treat Rev; 2015 Jan; 41(1):17-26. PubMed ID: 25434282
[TBL] [Abstract][Full Text] [Related]
3. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
4. Relevant infrastructural alterations in invasive pancreatic ductal adenocarcinoma.
Constantin VD; Mirancea GV; Moroşanu AM; Mirancea N
Rom J Morphol Embryol; 2015; 56(1):207-22. PubMed ID: 25826507
[TBL] [Abstract][Full Text] [Related]
5. Where and when does pancreatic carcinoma start?
Lüttges J; Hahn S; Klöppel G
Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
[TBL] [Abstract][Full Text] [Related]
6. Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma.
Kelly PJ; Shinagare S; Sainani N; Hong X; Ferrone C; Yilmaz O; Fernández-del Castillo C; Lauwers GY; Deshpande V
Am J Surg Pathol; 2012 May; 36(5):696-701. PubMed ID: 22367300
[TBL] [Abstract][Full Text] [Related]
7. Paucicellular infiltrating ductal carcinoma of pancreas: an unusual variant.
Fagih M; Serra S; Chetty R
Ann Diagn Pathol; 2007 Feb; 11(1):46-8. PubMed ID: 17240307
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma.
Andea A; Sarkar F; Adsay VN
Mod Pathol; 2003 Oct; 16(10):996-1006. PubMed ID: 14559982
[TBL] [Abstract][Full Text] [Related]
9. Invasive ductal adenocarcinoma of the pancreas may originate from the larger pancreatic duct: a study of 13 tumors less than 2 cm in diameter.
Suda K; Nobukawa B; Yamasaki S; Abe K; Matsukuma S; Suzuki F
J Hepatobiliary Pancreat Surg; 2007; 14(3):283-8. PubMed ID: 17520204
[TBL] [Abstract][Full Text] [Related]
10. [Radiological evaluation of pancreatic ductal adenocarcinoma].
Akai H; Otomo K
Gan To Kagaku Ryoho; 2012 Mar; 39(3):342-6. PubMed ID: 22421758
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN.
Yamaguchi K; Kanemitsu S; Hatori T; Maguchi H; Shimizu Y; Tada M; Nakagohri T; Hanada K; Osanai M; Noda Y; Nakaizumi A; Furukawa T; Ban S; Nobukawa B; Kato Y; Tanaka M
Pancreas; 2011 May; 40(4):571-80. PubMed ID: 21499212
[TBL] [Abstract][Full Text] [Related]
12. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
13. Tumour budding is a strong and independent prognostic factor in pancreatic cancer.
Karamitopoulou E; Zlobec I; Born D; Kondi-Pafiti A; Lykoudis P; Mellou A; Gennatas K; Gloor B; Lugli A
Eur J Cancer; 2013 Mar; 49(5):1032-9. PubMed ID: 23177090
[TBL] [Abstract][Full Text] [Related]
14. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
Pancreas; 2006 Apr; 32(3):281-7. PubMed ID: 16628084
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
[TBL] [Abstract][Full Text] [Related]
16. [Space-occupying lesion of the pancreas--how frequently not due to a suspected ductal adenocarcinoma?].
Turi S; Weickert U; Bohrer MH; Riemann JF
Z Gastroenterol; 2006 Feb; 44(2):161-6. PubMed ID: 16456757
[TBL] [Abstract][Full Text] [Related]
17. [Precursors to pancreatic cancer].
Søreide K; Immervoll H; Molven A
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
Biankin AV; Kench JG; Dijkman FP; Biankin SA; Henshall SM
Pathology; 2003 Feb; 35(1):14-24. PubMed ID: 12701679
[TBL] [Abstract][Full Text] [Related]
19. [Pathology of intraductal papillary-mucinous tumor of the pancreas].
Nobukawa B; Suda K; Yamasaki S; Takase M; Fukumura Y; Shiono S
Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):439-42. PubMed ID: 12854489
[TBL] [Abstract][Full Text] [Related]
20. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer.
Ikenaga N; Ohuchida K; Mizumoto K; Cui L; Kayashima T; Morimatsu K; Moriyama T; Nakata K; Fujita H; Tanaka M
Gastroenterology; 2010 Sep; 139(3):1041-51, 1051.e1-8. PubMed ID: 20685603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]